MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
DGX Quest Diagnostics
- 153.100
- +1.580+1.04%
Close Dec 20 16:00 ET
- 153.100
- 0.0000.00%
Post 20:01 ET
17.09BMarket Cap20.58P/E (TTM)
154.100High151.680Low1.40MVolume151.680Open151.520Pre Close214.29MTurnover1.26%Turnover Ratio20.44P/E (Static)111.62MShares165.32052wk High2.51P/B17.01BFloat Cap121.08452wk Low2.96Dividend TTM111.12MShs Float165.320Historical High1.93%Div YieldTTM1.60%Amplitude2.583Historical Low153.050Avg Price1Lot Size
About Quest Diagnostics Company
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Company Profile
SymbolDGX
Company NameQuest Diagnostics
Listing DateDec 17, 1996
Founded1967
CEOMr. James E. Davis
MarketNYSE
Employees48000
Fiscal Year Ends12-31
Address500 Plaza Drive
CitySecaucus
ProvinceNew Jersey
CountryUnited States of America
Zip Code07940
Phone1-973-520-2700
Company Executives
- Name
- Position
- Salary
- James E. Davis
- Chairman of the Board, President and Chief Executive Officer
- 12.67M
- Mark Delaney
- Senior Vice President and Chief Commercial Officer
- --
- Michael J. Deppe
- Senior Vice President, Corporate Controller and Chief Accounting Officer
- --
- Sam A. Samad
- Executive Vice President and Chief Financial Officer
- 3.98M
- Patrick Plewman
- Senior Vice President, Diagnostic Services
- --
- Catherine T. Doherty
- Senior Vice President, Regional Businesses
- 3.16M
- Michael E. Prevoznik
- Senior Vice President and General Counsel
- 2.25M
- Karthik Kuppusamy
- Senior Vice President, Clinical Solutions
- 2.02M
- Mark A. Gardner
- Senior Vice President, Molecular Genomics and Oncology
- --
- Tracey C. Doi
- Independent Director
- 300.44K
- Denise M. Morrison
- Independent Director
- 312.33K
- Wright L. Lassiter, III
- Independent Director
- 300.44K
- Robert B. Carter
- Independent Director
- --
- Timothy M. Ring
- Lead Independent Director
- 345.94K
- Timothy L. Main
- Independent Director
- 315.44K
- Gary M. Pfeiffer
- Independent Director
- 342.12K
- Dr. Luis A. Diaz, Jr,M.D.
- Independent Director
- 280.41K
- Vicky B. Gregg
- Independent Director
- 315.73K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
